Frontier Biosciences' Management Buyout

Frontier Biosciences raised a round of funding on September 21, 2015. Investors include Management Buyout (MBO).

Frontier Biosciences is a global contract research organization (CRO) providing drug discovery, development, and regulatory guidance in China.…

Articles about Frontier Biosciences' Management Buyout: